KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $145.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 7.41% to $145.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $570.0 million through Dec 2025, up 15.62% year-over-year, with the annual reading at $570.0 million for FY2025, 15.62% up from the prior year.
  • Depreciation & Amortization (CF) hit $145.0 million in Q4 2025 for Quest Diagnostics, up from $142.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $145.0 million in Q4 2025 to a low of $100.0 million in Q2 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $117.4 million across 5 years, with a median of $111.5 million in 2023.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 6.03% in 2023 and later increased 23.85% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $106.0 million in 2021, then rose by 9.43% to $116.0 million in 2022, then fell by 6.03% to $109.0 million in 2023, then grew by 23.85% to $135.0 million in 2024, then rose by 7.41% to $145.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for DGX at $145.0 million in Q4 2025, $142.0 million in Q3 2025, and $143.0 million in Q2 2025.